The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index; 1 of the 25 sources its claims cite were checked for support.
Distribution and characteristics of malignant tumours by lung lobe
Open accessAbstract
The aim of this study was to investigate the distribution and characteristics of malignant tumours between the lung lobes and whether the diagnosis, treatment, and outcome differed based on location. This study is based on 10,849 lung cancer patients diagnosed in 2018-2022 with complete data on the location and characteristics of the tumours. The proportions of tumours in each lobe divided by its volume were termed the relative proportion. The right upper lobe comprised 31.2% of the tumours and 17.6% of the lung volume. The relative proportion of 1.77 was higher than in the other lobes (p < 0.001). After adjusting for age, sex, stage, and histology, the location of the tumour was found to be a significant independent predictor for resection but not for survival. CONCLUSION: The main finding of the right upper lobe as a site of predilection for lung cancer is similar to tuberculosis and pneumoconiosis. This may be explained that most of the inhaled air, containing bacilli, inorganic particles or tobacco smoke, is distributed to the upper lobes.
Overview
CoChat Summary
TL;DR
Using national Norwegian registry data on 10,849 lung cancer patients diagnosed in 2018–2022, the study found that malignant tumours were not evenly distributed across lung lobes, with the right upper lobe showing the highest relative proportion (1.77). Lobe location was associated with diagnosis and treatment patterns, but not with survival after adjustment.
Key findings
- In 10,849 eligible patients, the right upper lobe (RUL) contained 31.2% of tumours but only 17.6% of lung volume, giving the highest relative proportion of 1.77 (p < 0.001).
- The right middle lobe (RML) had the lowest relative proportion of tumours (0.64) but the highest proportion of neuroendocrine tumours: 26.1% versus 15.3% on average.
- Tumours in the upper lobes were more often treated with curative radiotherapy (20.1% vs. 18.3% in lower lobes), while surgical resection was more common in lower lobes (30.4% vs. 27.8%; p < 0.001).
- After adjustment for age, sex, stage, histology, and EGFR status, lobe location was an independent predictor of resection but not of survival; the study reported 5-year relative survival of 33.7%.
Methods
- Population-based registry study using Cancer Registry of Norway data, restricted to lung cancer patients diagnosed in 2018–2022 with complete data on tumour location and characteristics.
- Final analytic sample: 10,849 patients; analyses used complete-case data for most results, with multiple imputation in logistic and Cox regression models for missing side/lobe, histology, cTNM, and EGFR data.
- Main analyses included descriptive comparisons by lobe, relative proportions of tumours by lobe volume, logistic regression for surgery, and Cox regression for survival, adjusted for age, sex, stage, histology, EGFR status, and first treatment.
Limitations
- The paper states limitations of missing information on smoking, performance status, and socioeconomic status, and that the study is retrospective.
- The volume reference used to calculate relative proportions came from Yamada et al.’s healthy volunteers in another population, not Nordic volunteers; the paper notes the variation was low, but this remains a potential limitation.
- Evident from the text: patients with tumours in the main bronchus, overlapping lesions, unknown location, or incomplete diagnostic data were excluded, so findings may not generalize to all lung cancer patients.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
1 Valid · 0 Not valid · 11 Not checked · 50 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The increased proportion of SCLC, the tumour with the strongest correlation to tobacco smoke [31], in the upper lobes may support the view that these lobes are most exposed to the inhaled smoke.”
§ Distribution and characteristics of malignant tumours by lung lobe > Discussion
What the sources say
- Partly supportedcites [31] Pesch B, Kendzia B, Gustavsson P, Jöckel KH, Johnen G, Pohlabeln H, Olsson A, Ahrens W, Gross IM, Brüske I, et al. Cigarette smoking and lung cancer–relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int J Cancer. 2012;131(5):1210–9. sourceExperimental — accuracy not yet measured
The Discussion identifies SCLC and squamous cell carcinoma as the subtypes with the highest smoking-related risks. The Results do not establish SCLC as uniquely the most strongly associated: among women smoking at least 60 pack-years, the reported risk estimate is higher for squamous cell carcinoma than for SCLC. The citation is attached to the smoking-association description, not the statement about upper-lobe exposure. (LLM, conf=0.86)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“curative radiotherapy was more often performed in the upper lobes.”
- Also stated in: § Treatment · plain
“Stereotactic body radiation therapy (SBRT), or curative radiotherapy, was given to 20.1% of the patients with tumours in the upper lobes and 18.3% in the lower lobes (p = 0.016).”
§ Distribution and characteristics of malignant tumours by lung lobe > Abstract > Results
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Treatment · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Those with tumours on the right side had a mean age of 70.3 years and were younger than those with left-sided tumour (70.9 years, p < 0.001).”
§ Distribution and characteristics of malignant tumours by lung lobe > Results > Age
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Surgical resection was more often performed in patients with tumours in the lower lobes, and curative radiotherapy was more often performed in the upper lobes.”
- Also stated in: § Treatment · plain
“Surgical resection was performed in 27.8%, and 30.4% of patients with tumours in the upper and lower lobes, respectively (p < 0.001).”
§ Distribution and characteristics of malignant tumours by lung lobe > Abstract > Results
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Treatment · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The right upper lobe comprised 31.2% of the tumours and 17.6% of the lung volume.”
§ Distribution and characteristics of malignant tumours by lung lobe > Abstract > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
25 more claims
Create a free account to see all 62 claims and to verify the 3 references still open.
- It may state two separate claims as one. 27
- Probably not a substantial claim. 7
- The quote only partly states this claim. 1
Citations
Cites
Multiple imputation using chained equations: Issues and guidance for practice
White, I. R., Royston, P., & Wood, A. M. (2011) · Statistics in Medicine · doi:10.1002/sim.4067 · Cited by 9,792 · cited 1×
“The imputation model was run 30 times using the mi impute chained command in Stata [17].”
MethodGoldstraw, P., Chansky, K., Crowley, J., Rami-Porta, R., Asamura, H., Eberhardt, W. E. E., Nicholson, A. G., Groome, P., Mitchell, A., Bolejack, V., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2015.09.009 · Cited by 4,607
EGFR Mutations and Lung Cancer
da Cunha Santos, G., Shepherd, F. A., & Tsao, M. S. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130206 · Cited by 949
Larsen, I. K., Småstuen, M., Johannesen, T. B., Langmark, F., Parkin, D. M., Bray, F., & Møller, B. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.037 · Cited by 848 · cited 1×
“The quality, comparability, completeness, validity, and timeliness of the data in the CRN have been evaluated to be high, with an estimated completeness of 99.2% for lung cancer [14, 15].”
BackgroundInfluentialSelf-citationLung adenocarcinoma promotion by air pollutants
Hill, W., Lim, E. L., Weeden, C. E., Lee, C., Augustine, M., Chen, K., Kuan, F.-C., Marongiu, F., Evans, E. J., Moore, D. A., et al. (2023) · Nature · doi:10.1038/s41586-023-05874-3 · Cited by 808 · cited 1×
“Further, Hill et al. have recently described the significance of air pollut-ants in inducing EGFR-driven ACs in never smokers [22].”
BackgroundRegional distribution of inspired gas in the lung.
Milic-Emili, J., Henderson, J. A., Dolovich, M. B., Trop, D., & Kaneko, K. (1966) · Journal of Applied Physiology · doi:10.1152/jappl.1966.21.3.749 · Cited by 762
On Estimation in Relative Survival
Perme, M. P., Stare, J., & Estève, J. (2012) · Biometrics · doi:10.1111/j.1541-0420.2011.01640.x · Cited by 661 · cited 2×
“Relative survival was estimated using the Pohar Perme estimator [19], and here, the 95% CI was calculated using the delta method and a log–log transformation.”
MethodJohnson, R. L. (2003) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2003-127-1532-rbp · Cited by 558
Pesch, B., Kendzia, B., Gustavsson, P., Jöckel, K., Johnen, G., Pohlabeln, H., Olsson, A., Ahrens, W., Gross, I. M., Brüske, I., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27339 · Cited by 509
Estimating and Modeling Relative Survival
Dickman, P. W., & Coviello, E. (2015) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x1501500112 · Cited by 353 · cited 1×
“All-cause (overall) median survival and relative survival [18, 19] were estimated for each patient characteristic.”
Method
Research works printed but not linked: 3
- Corryn B, Nicholoson A. Pathology Og the lungs. 3rd ed. Churchill Livingston Elsevier; 2011.
- Liavaag K. Bronchiogenic Carcinoma. Acta Chir Scand. 1949;98:182–204.
- Kumar. V, Abbas. A. J A: Robbins Basic Pathology. 10th ed. Elsevier; 2017.
Cited by
Hosseinabadi, R. B., & Rajabi, H. (2025) · Journal of Radiation Research and Applied Sciences · doi:10.1016/j.jrras.2025.101361 · Cited by 2
Lu, Z., Zheng, P., Liao, Y., Wang, H., Zhu, K., Chen, Y., Lin, Z., Huang, X., Wang, Y., & Yang, J. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000003770 · Cited by 1
Tămaș, F., Tamas, C. I., Suciu, B. A., & Bălașa, A. F. (2025) · Cureus · doi:10.7759/cureus.80200 · Cited by 3
“This distribution is influenced by factors such as prolonged exposure to inhaled carcinogens, lower ventilation and clearance in the upper lobes, and differences in lung perfusion, with lower lobes having better blood supply and higher oxygenation [52,53].”
Right Tracheal Bronchus Identifcation and Classifcation
Liu, Y., Che, Z., Zhang, S., et al. (2024) · Indian Journal of Surgery · doi:10.1007/s12262-024-04232-5
Yu, W., Long, L., Hou, Q., & Yi, B. (2025) · PLoS ONE · doi:10.1371/journal.pone.0321955
“Previous studies have also observed that lung cancer occur more frequently in the upper lobes compared to the middle and lower lobes [9,13,14],which aligns with our findings.”
Metadata
- Authors
- Nilssen, Y., Brustugun, O. T., Fjellbirkeland, L., Helland, Å., Møller, B., Wahl, S. G. F., & Solberg, S.
- Affiliations
- Cancer Registry of Norway (NO)
- University of Oslo (NO)
- Oslo University Hospital (NO)
- St Olav's University Hospital (NO)
- Corresponding author
- Solberg, Steinar
- ORCID
- Venue
- BMC Pulmonary Medicine
- Published
- 2024-03-04
- Volume
- 24
- Issue
- 1
- Pages
- 106-106
- ISSN
- 1471-2466 (ISSN-L)
- PMC
- PMC10910834
- OpenAlex
- W4392376331
- Cited by
- 11
- References
- 25
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 1
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- BMC Pulmonary Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- NORA - Norwegian Open Research Archives (submittedVersion, cc-by)
- Funders
- University of Oslo
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Lung Cancer Research Studies
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- lung cancer, tumor location, lung lobes, right upper lobe, neuroendocrine tumors, surgical resection, definitive radiotherapy, survival, histology, tobacco smoke, inhaled particles
- MeSH terms
- Humans, Lung, Lung Neoplasms, Neuroendocrine Tumors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Distribution and characteristics of malignant tumours by lung lobe. https://app.cochat.ai/papers/10.1186/s12890-024-02918-w
- The paper
- Nilssen, Y., Brustugun, O. T., Fjellbirkeland, L., Helland, Å., Møller, B., Wahl, S. G. F., & Solberg, S. (2024). Distribution and characteristics of malignant tumours by lung lobe. BMC Pulmonary Medicine. https://doi.org/10.1186/s12890-024-02918-w
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.